VanEck Biotech ETF (NASDAQ:BBH) Shares Sold by Jones Financial Companies Lllp

Jones Financial Companies Lllp reduced its holdings in shares of VanEck Biotech ETF (NASDAQ:BBH) by 4.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,617 shares of the company’s stock after selling 108 shares during the period. Jones Financial Companies Lllp’s holdings in VanEck Biotech ETF were worth $411,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Kovitz Investment Group Partners LLC increased its position in shares of VanEck Biotech ETF by 4.6% during the third quarter. Kovitz Investment Group Partners LLC now owns 3,186 shares of the company’s stock worth $565,000 after acquiring an additional 141 shares during the period. Flagship Harbor Advisors LLC grew its stake in VanEck Biotech ETF by 12.1% during the 4th quarter. Flagship Harbor Advisors LLC now owns 1,984 shares of the company’s stock worth $311,000 after purchasing an additional 214 shares in the last quarter. Truvestments Capital LLC acquired a new position in VanEck Biotech ETF during the 3rd quarter worth $44,000. FSA Wealth Management LLC purchased a new stake in VanEck Biotech ETF during the 3rd quarter worth about $54,000. Finally, Coastline Trust Co purchased a new position in shares of VanEck Biotech ETF in the 3rd quarter valued at about $59,000. Hedge funds and other institutional investors own 32.05% of the company’s stock.

VanEck Biotech ETF Stock Performance

Shares of VanEck Biotech ETF stock opened at $161.78 on Wednesday. The business has a 50-day simple moving average of $162.42 and a 200-day simple moving average of $168.09. The company has a market cap of $394.74 million, a PE ratio of 30.97 and a beta of 0.85. VanEck Biotech ETF has a one year low of $151.35 and a one year high of $183.64.

VanEck Biotech ETF Dividend Announcement

The company also recently declared a dividend, which was paid on Tuesday, December 24th. Shareholders of record on Monday, December 23rd were issued a dividend of $1.2517 per share. The ex-dividend date of this dividend was Monday, December 23rd.

About VanEck Biotech ETF

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.